Skip to main content
SpringerLink
Log in

Lung Cancer and Pleural Mesothelioma

  • Chapter
Radiation Oncology for Cure and Palliation

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 164 Accesses

Abstract

Carcinomas arising in the lung are the most common noncutaneous cancers in humans in the United States. In the year 2001, the estimated number of new diagnoses of lung cancer in this country was 169,500 (55% in men, 45% in women) [1]. These tumors constituted about 14% of the cancer incidence (men, 15%; women, 13%) and 28% of the cancer-related mortality (men, 32%; women, 28%) exclusive of skin cancers and carcinoma in situ of the cervix [2]. Lung cancer has been increasing in women and now exceeds breast cancer in the frequency of cancer-related mortality.

“From treating patients as cases and from making the cure of the desease more grevous than the endurance of the same — Good Lord deliver us”

Sir Robert Hutchinson

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics 2000. CA Cancer J Clin 50: 7–33

    Article  PubMed  CAS  Google Scholar 

  2. Figlin RA, Cameron RB, Turrisi AT III (2001) Non small cell lung cancer. In: Haskell CM (ed) Cancer treatment, 5th edn. Saunders, Philadelphia, pp 598–628

    Google Scholar 

  3. Travis WD, Colby TV, Corrin B et al (1999) World Health Organization Pathology Panel: World Health Organization. Histological typing of lung and pleural tumors. International histological classification of tumors, 3rd edn. Springer, Berlin Heidelberg New York

    Google Scholar 

  4. Paulsen DL (1971) Superior sulcus tumors: results of combined therapy. N Y State J Med 71: 2050–2057

    Google Scholar 

  5. Lassen U, Hansen HH (2001) Small cell carcinoma of the lung. In: Haskell CM (ed) Cancer treatment, 5th edn. Saunders, Philadelphia, pp 629–639

    Google Scholar 

  6. Hirsch FR, Osterlind K, Hanssen HH (1983) The prognostic significance of histopathologic subtyping of small cell carcinoma of the lung according to the classification of the World Health Organization. Cancer 52: 2144–2150

    Article  PubMed  CAS  Google Scholar 

  7. Line DH, Deeley TJ (1971) The necropsy findings in carcinoma of the bronchus. Br J Dis Chest 65: 238–242

    Article  PubMed  CAS  Google Scholar 

  8. Emami B, Graham MV (1998) Lung. In: Perez CA, Brady LW (eds) Principles and practice of radiation oncology, 3rd edn. Lippincott-Raven, Philadelphia, pp 1181–1220

    Google Scholar 

  9. Gray H (1995) Gray’s anatomy: the anatomical basis of medicine and surgery. Churchill-Livingstone, New York

    Google Scholar 

  10. Nagaishi C (1972) Functional anatomy and histology of the lung. University Park Press, Baltimore

    Google Scholar 

  11. Nathanson L, Hall T (1974) A spectrum of tumors that produce paraneoplastic syndromes: lung tumors. How they produce their syndromes. Ann N Y Acad Sci 230: 367–377

    Article  PubMed  CAS  Google Scholar 

  12. Scott W, Schwabe J, Gupta N et al (1994) Positron emission tomography of lung tumors and mediastinal lymph nodes using ‘8F-fluorodeoxyglucose. Ann Thorac Surg 58: 698–703

    Article  PubMed  CAS  Google Scholar 

  13. Erozan Y, Frost J (1974) Cystopathological diagnosis of lung cancer. Semin Oncol 1: 191–198

    PubMed  CAS  Google Scholar 

  14. Doale P, Bode F, Kini S (1976) Diagnostic accuracy in lung cancer: comparison of techniques used in association with flexible fiberoptic bronchoscopy. Chest 69: 752–757

    Article  Google Scholar 

  15. Richardson R, Zavala D, Jukerjee P (1974) The use of fiber-optic bronchoscopy and brush biopsy in the diagnosis of suspected pulmonary malignancy. Am Rev Respir Dis 109: 63–66

    PubMed  CAS  Google Scholar 

  16. Sagel S, Ferguson T, Forrest J (1978) Percutaneous trans-thoracic aspiration needle biopsy. Ann Thorac Surg 26: 399–405

    Article  PubMed  CAS  Google Scholar 

  17. Skinner W (1979) Pulmonary neoplasms diagnosed with transthoracic needle biopsy. Cancer 43: 1533–1540

    Article  Google Scholar 

  18. Grover F (1994) The role of CT and MRI in staging of the mediastinum. Chest 106: 3918–3968

    Article  Google Scholar 

  19. Thomas P (1994) The role of mediastinal staging of lung cancer. Chest 106: 331S - 333S

    PubMed  Google Scholar 

  20. Mountain CF, Carr D, Anderson W (1974) A system for the clinical staging of lung cancer. Am J Roentgenol 120: 130–138

    Article  CAS  Google Scholar 

  21. Mountain CF (1989) A new international staging system for lung cancer. Chest 89 [Suppl]: 225S - 2395

    Google Scholar 

  22. Mountain C (1997) Revisions in the International System for Staging Lung Cancer. Chest 111: 1710–1717

    Article  PubMed  CAS  Google Scholar 

  23. Mountain C, Dresler C (1997) Regional lymph node classification for lung cancer staging. Chest 111: 1718–1723

    Article  PubMed  CAS  Google Scholar 

  24. Curran WJ Jr (2001) Small cell lung cancer. In: Gunderson LL, Tepper JE (eds) Clinical radiation oncology, 1st edn. Churchill Livingstone, Edinburgh

    Google Scholar 

  25. Green RA, Humphrey E, Close H et al (1969) Alkylating agents in bronchogenic carcinoma. Am J Med 49: 360–367

    Google Scholar 

  26. Eaton W, Maurer H, Glicksman A et al (1981) The relationship of infield recurrences to prescribed tumor dose in small cell carcinoma of the lung (abstract). Int J Radiat Oncol Biol Phys 7: 1223

    Article  Google Scholar 

  27. White J, Chen R, McCracken Jet al (1982) The influence of radiation therapy quality control on survival, response and sites of relapse in oat cell carcinoma of the lung. Preliminary report of a SWOG study. Cancer 50: 1084–1090

    Google Scholar 

  28. Kies MS, Mira JG, Crowley JJ et al (1987) Multimodal therapy for limited small cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders and with wide-field versus reduced-field radiation in partial responders. A Southwest Oncology Group Study. J Clin Oncol 5: 592–600

    Google Scholar 

  29. Liengswangwong V, Bonner JA, Shaw EG et al (1994) Limited-stage small cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy. J Clin Oncol 12: 496–502

    PubMed  CAS  Google Scholar 

  30. Arriagada R, LeCakvalier T, Borie F et al (1995) Prophylactic cranial irradiation for patients with small lung cancer in complete remission. J Natl Cancer Inst 87: 183–190

    Article  PubMed  CAS  Google Scholar 

  31. Gregor A, Cull A, Stephens RJ et al (1995) Effects of prophylactic irradiation for patients with small cell lung cancer in complete response (abstract). Eur J Cancer 31A: S19

    Article  Google Scholar 

  32. Arriagada R, Duperin A, Pignon JP et al (1998) Prophylactic cranial irradiation in patients with small cell lung cancer in complete remission (abstract). Proc Am Soc Clin Oncol 17: 457

    Google Scholar 

  33. Ginsberg R, Rubinstein L (1983) Randomized trial of lobectomy versus limited resection for T1 No non-small cell lung cancer. J Thorac Cardiovasc Surg 86: 654–658

    PubMed  CAS  Google Scholar 

  34. Wagner H Jr (2001) Non-small cell lung cancer. In: Gunderson LL, Tepper JE (eds) Clinical radiation oncology, 1st edn. Churchill Livingstone, Edinburgh, pp 600–629

    Google Scholar 

  35. Dillman RO, Seagreen SL, Herdon J, Green MR (1993) Randomized trial of induction chemotherapy plus radiation therapy vs RT alone in Stage III non small cell lung cancer (NSCLC): five-year follow-up of CALGB. Proc ASCO 12: 329

    Google Scholar 

  36. Le Chevalier T, Arriagada R, Tarayre M et al (1992) Significant effect of adjuvant chemotherapy on survival in locally advanced non-small cell lung carcinoma. J Natl Cancer Inst 84: 58

    Article  PubMed  Google Scholar 

  37. Mira JG, Miller TP, Crowley JJ (1990) Chest irradiation (RT) vs chest RT + chemotherapy + prophylactic brain RT in localized non small cell lung cancer: a SWOG randomized study. Int J Radiat Oncol Biol Phys 19 [Suppl]: 145

    Article  Google Scholar 

  38. Morton RF, Jett JR, McGinnis WL et al (1991) Thoracic radiation therapy alone compared with combined chemotherapy for locally unresectable non small cell lung cancer: a randomized, phase III trial. Ann Intern Med 115: 681–686

    Article  PubMed  CAS  Google Scholar 

  39. Schaake-Koning C, van den Bogaert W, Dalesio O et al (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326: 524–530

    Article  PubMed  CAS  Google Scholar 

  40. Ansari R, Tohar SR, Fisher W et al (1991) A phase III study of thoracic irradiation with or without concomitant cisplatin in loco-regional unresectable non small cell lung cancer (NSCLC): a Hoosier Oncology Group protocol. Am Soc Clin Oncol 10: 241–243

    Google Scholar 

  41. Trovo MG, Minatel E, Veronesi A et al (1990) Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma: a randomized study. Cancer 65: 400–404

    Article  PubMed  CAS  Google Scholar 

  42. Lutz ST, Hwang DT, Ferguson C et al (1997) A retrospective quality of life analysis using the lung cancer symptom scale in patients treated with palliative radiotherapy for advanced non-scale cell lung cancer. Int J Radiat Oncol Biol Phys 37 (1): 117–122

    Article  PubMed  CAS  Google Scholar 

  43. Teo P, Tai TH, Choy D, Tsui KH (1988) A randomized study on palliative radiation therapy for inoperable non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 14: 867–871

    Article  PubMed  CAS  Google Scholar 

  44. Wagner H Jr. Non-small cell lung cancer, Chpt 32 in Clinical Radiation Oncology. Gunderson LL, Tepper JE (eds), Churchill Livingstone, 1st edn. 2000, pp 600–629

    Google Scholar 

  45. Komaki R, Cox JD. The Lung and Thymus, Chpt 14 in Moss: Radiation Oncology: Rationale, Technique, Results ed Cox JD Modby 7th edn. 1994, pp 320–351

    Google Scholar 

  46. Loeffler JS, Patchell RA, Saway AR. Metastatic brain cancer from Cancer: Principles and Practice of Oncology, 5th edn., De Vita V Jr, Hellman S, Rosenberg SA (eds) Lippincott-Raven Publishers, Philadelphia 1997, pp 2523–2536

    Google Scholar 

  47. Stoll BA. Natural history, prognosis and staging of bone metastases, in Stoll BA, Parboo S (eds). Bone Metastases Monitoring and Treatment. New York, NY. Raven 1983, pp 1–20

    Google Scholar 

  48. Sculier JP, Feld R (1985) Superior vena cava obstruction syndrome: Recommendations and management. Cancer Treat Rev 12 (3): 210–218

    Article  Google Scholar 

  49. Yohalom J. Superior vena cava syndrome, in Cancer: Principles and Practice of Oncology, 5th edn., De Vita VT Jr, Hellman S, Rosenberg SA, Lippincott-Raven Publishers, Philadelphia 1997, pp 2469–2476

    Google Scholar 

  50. Langendijk JA, Ten Velde GPM, Aaronson NK et al (2000) Quality of life after palliative radiotherapy in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 47 (1): 149–155

    Article  PubMed  CAS  Google Scholar 

  51. Simpson R, Francis ME, Perez-Tamayo R et al (1985) Palliative radiotherapy for inoperable carcinoma of the lung: Final report of a RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys 11: 751–758

    Google Scholar 

  52. Bleehen NM, Girling FJ, Macking D, Stephens RJ (1992) A medical research council (MRC) randomized trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small cell lung cancer ( NSCLC) and poor performance status. Br J Cancer 65: 934–941

    Google Scholar 

  53. Langendijk JA, Aaronson JMA, deJong GPM et al (2001) Prospective study on quality od life before and after radical radiotherapy in non-small cell lung cancer. Jrn Clin Oncol 19 (8): 2123–2133

    CAS  Google Scholar 

  54. NCCN Practice Guidelines for Cancer-Related Fatigue. Version 2000. Oncology 14 (11A): 151–161

    Google Scholar 

  55. Reddy SP, Marks JE (1990) Total acelectasis of the lung secondary to malignant airway obstruction. Am J Clin Oncol 13 (5): 394–400

    Article  PubMed  CAS  Google Scholar 

  56. Kelly JF, Delclos ME, Morice RC et al. High dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: The 10-year MD Anderson Cancer Center Experience

    Google Scholar 

  57. Chetty KG, Moran EM, Sassoon CSH et al (1989) Effect of radiation therapy on bronchial obstruction due to bronchogenic carcinoma. Chest 96 (3): 582–584

    Article  Google Scholar 

  58. Majid OA, Lee S, Khushalani S, Seydel HG (1986) The response of atelectsiss from lung cancer to radiation therapy. Int J Radiat Oncol Biol Phys 12: 231–232

    Article  PubMed  CAS  Google Scholar 

  59. Chang L-FL, Horvath J, Peyton W, Lang S-S (1994) High dose rate afterloading intraluminal Brachytherapy in malignant airway obstruction of lung cancer. int J Radiat Oncol Biol Phys 28 (3): 589–596

    Article  CAS  Google Scholar 

  60. Mehta M, Petereit D, Chosy L et al (1992) Sequential comparison of low dose rate and hyperfractionated high dose rate endobronchial radiation for malignant airway obstruction. Int J Radiat Oncol Biol Phys 23: 133–139

    Article  PubMed  CAS  Google Scholar 

  61. Raju PI, Roy T, McDonald RD et al (1993) Ir-192 low dose rate endobronchial brachytherapy in the treatment of malignant airway obstruction. Int J Radiat Oncol Biol Phys 27: 677–680

    Article  PubMed  CAS  Google Scholar 

  62. Spieser B, Spratling L (1990) intermediate dose rate remote afterloading brachytherapy for intraluminal control of bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 18: 1443–1448

    Google Scholar 

  63. Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer 24. statistics 2000. CA Cancer J Clin 50: 7–33

    Article  PubMed  CAS  Google Scholar 

  64. Figlin RA, Cameron RB, Turrisi AT III (2001) Non small cell lung cancer. In: Haskell CM (ed) Cancer treatment, 25. 5th edn. Saunders, Philadelphia, pp 598–628

    Google Scholar 

  65. Travis WD, Colby TV, Corrin B et al (1999) World Health Organization Pathology Panel: World Health Organiza- 26. tion. Histological typing of lung and pleural tumors. International histological classification of tumors, 3rd edn. Springer, Berlin Heidelberg New York

    Google Scholar 

  66. Paulsen DL (1971) Superior sulcus tumors: results of 27. combined therapy. N Y State J Med 71: 2050–2057

    Google Scholar 

  67. Lassen U, Hansen HH (2001) Small cell carcinoma of the lung. In: Haskell CM (ed) Cancer treatment, 5th edn. Saunders, Philadelphia, pp 629–639 28.

    Google Scholar 

  68. Hirsch FR, Osterlind K, Hanssen HH (1983) The prognostic significance of histopathologic subtyping of small cell carcinoma of the lung according to the classification of the World Health Organization. Cancer 52: 2144–2150

    Article  PubMed  CAS  Google Scholar 

  69. Line DH, Deeley TJ (1971) The necropsy findings in carcinoma of the bronchus. Br J Dis Chest 65: 238–242

    Article  PubMed  CAS  Google Scholar 

  70. Emami B, Graham MV (1998) Lung. In: Perez CA, Brady 29. LW (eds) Principles and practice of radiation oncology, 3rd edn. Lippincott-Raven, Philadelphia, pp 1181–1220

    Google Scholar 

  71. Gray H (1995) Gray’s anatomy: the anatomical basis of medicine and surgery. Churchill-Livingstone, New York 30.

    Google Scholar 

  72. Nagaishi C (1972) Functional anatomy and histology of the lung. University Park Press, Baltimore

    Google Scholar 

  73. Nathanson L, Hall T (1974) A spectrum of tumors that 31. produce paraneoplastic syndromes: lung tumors. How they produce their syndromes. Ann N Y Acad Sci 230: 367–377 32.

    Google Scholar 

  74. Scott W, Schwabe J, Gupta N et al (1994) Positron emission tomography of lung tumors and mediastinal lymph nodes using 18F-fluorodeoxyglucose. Ann Thorac Surg 58: 698–703 33.

    Google Scholar 

  75. Erozan Y, Frost J (1974) Cystopathological diagnosis of lung cancer. Semin Oncol 1: 191–198

    PubMed  CAS  Google Scholar 

  76. Doale P, Bode F, Kini S (1976) Diagnostic accuracy in lung 34. cancer: comparison of techniques used in association with flexible fiberoptic bronchoscopy. Chest 69: 752–757

    Article  Google Scholar 

  77. Richardson R, Zavala D, Jukerjee P (1974) The use of fiber-optic bronchoscopy and brush biopsy in the diagnosis of 35. suspected pulmonary malignancy. Am Rev Respir Dis 109: 63–66

    PubMed  CAS  Google Scholar 

  78. Sagel S, Ferguson T, Forrest J (1978) Percutaneous trans-thoracic aspiration needle biopsy. Ann Thorac Surg 26: 399–405 36.

    Google Scholar 

  79. Skinner W (1979) Pulmonary neoplasms diagnosed with transthoracic needle biopsy. Cancer 43: 1533–1540

    Article  Google Scholar 

  80. Grover F (1994) The role of CT and MRI in staging of the mediastinum. Chest 106: 3918–3968 37.

    Google Scholar 

  81. Thomas P (1994) The role of mediastinal staging of lung cancer. Chest 106: 331S - 333S

    PubMed  Google Scholar 

  82. Mountain CF, Carr D, Anderson W (1974) A system for the clinical staging of lung cancer. Am J Roentgenol 120: 130–138 38.

    Google Scholar 

  83. Mountain CF (1989) A new international staging system for lung cancer. Chest 89 [Suppl]: 2255–239S

    Google Scholar 

  84. Mountain C (1997) Revisions in the International System for Staging Lung Cancer. Chest 111: 1710–1717

    Article  PubMed  CAS  Google Scholar 

  85. Mountain C, Dresler C (1997) Regional lymph node classification for lung cancer staging. Chest 111: 1718–1723

    Article  PubMed  CAS  Google Scholar 

  86. Curran WJ Jr (2001) Small cell lung cancer. In: Gunderson LL, Tepper JE (eds) Clinical radiation oncology, 1st edn. Churchill Livingstone, Edinburgh

    Google Scholar 

  87. Green RA, Humphrey E, Close H et al (1969) Alkylating agents in bronchogenic carcinoma. Am J Med 49: 360–367

    Google Scholar 

  88. Eaton W, Maurer H, Glicksman A et al (1981) The relationship of infield recurrences to prescribed tumor dose in small cell carcinoma of the lung (abstract). Int J Radiat Oncol Biol Phys 7: 1223

    Article  Google Scholar 

  89. White J, Chen R, McCracken J et al (1982) The influence of radiation therapy quality control on survival, response and sites of relapse in oat cell carcinoma of the lung. Preliminary report of a SWOG study. Cancer 50: 1084–1090

    Google Scholar 

  90. Kies MS, Mira JG, Crowley JJ et al (1987) Multimodal therapy for limited small cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders and with wide-field versus reduced-field radiation in partial responders. A Southwest Oncology Group Study. J Clin Oncol 5: 592–600

    Google Scholar 

  91. Liengswangwong V, Bonner JA, Shaw EG et al (1994) Limited-stage small cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy. J Clin Oricol 12: 496–502

    CAS  Google Scholar 

  92. rriagada R, LeCakvalier T, Borie F et al (1995) Prophylactic cranial irradiation for patients with small lung cancer in complete remission. J Natl Cancer Inst 87: 183–190

    Article  Google Scholar 

  93. Gregor A, Cull A, Stephens RJ et al (1995) Effects of prophylactic irradiation for patients with small cell lung cancer in complete response (abstract). Eur J Cancer 31A: S19

    Article  Google Scholar 

  94. Arriagada R, Duperin A, Pignon JP et al (1998) Prophylactic cranial irradiation in patients with small cell lung cancer in complete remission (abstract). Proc Am Soc Clin Oncol 17: 457

    Google Scholar 

  95. Ginsberg R, Rubinstein L (1983) Randomized trial of lobectomy versus limited resection for T1 No non-small cell lung cancer. J Thorac Cardiovasc Surg 86: 654–658

    PubMed  CAS  Google Scholar 

  96. Wagner H Jr (2001) Non-small cell lung cancer. In: Gunderson LL, Tepper JE (eds) Clinical radiation oncology, 1st edn. Churchill Livingstone, Edinburgh, pp 600–629

    Google Scholar 

  97. Dillman RO, Seagreen SL, Herdon J, Green MR (1993) Randomized trial of induction chemotherapy plus radiation therapy vs RT alone in Stage III non small cell lung cancer (NSCLC): five-year follow-up of CALGB. Proc ASCO 12: 329

    Google Scholar 

  98. Le Chevalier T, Arriagada R, Tarayre M et al (1992) Significant effect of adjuvant chemotherapy on survival in locally advanced non-small cell lung carcinoma. J Natl Cancer Inst 84: 58

    Article  PubMed  Google Scholar 

  99. Mira JG, Miller TP, Crowley JJ (1990) Chest irradiation (RT) vs chest RT + chemotherapy + prophylactic brain RT in localized non small cell lung cancer: a SWOG randomized study (abstract). Int J Radiat Oncol Biol Phys 19 [Suppl]: 145

    Article  Google Scholar 

  100. Morton RF, Jett JR, McGinnis WL et al (1991) Thoracic radiation therapy alone compared with combined chemotherapy for locally unresectable non small cell lung cancer: a randomized, phase III trial. Ann Intern Med 115: 681–686

    Article  PubMed  CAS  Google Scholar 

  101. Schaake-Koning C, van den Bogaert W, Dalesio O et al (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326: 524–530

    Article  PubMed  CAS  Google Scholar 

  102. Ansari R, Tohar SR, Fisher W et al (1991) A phase III study of thoracic irradiation with or without concomitant cisplatin in loco-regional unresectable non small cell lung cancer (NSCLC): a Hoosier Oncology Group protocol. Am Soc Clin Oncol 10: 241

    Google Scholar 

  103. Trovo MG, Minatel E, Veronesi A et al (1990) Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma: a randomized study. Cancer 65: 400–404

    Article  PubMed  CAS  Google Scholar 

  104. Lutz ST, Hwang DT, Ferguson C et al (1997) A retrospective quality of life analysis using the lung cancer symptom scale in patients treated with palliative radiotherapy for advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 37: 117–122

    Article  PubMed  CAS  Google Scholar 

  105. Teo P, Tai TH, Choy D, Tsui KH (1988) A randomized study on palliative radiation therapy for inoperable non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 14: 867–871

    Article  PubMed  CAS  Google Scholar 

  106. Wagner H Jr (2000) Non-small cell lung cancer. In: Gunderson LL, Tepper JE (eds) Clinical radiation oncology, 1st edn. Churchill Livingstone, Edinburgh, pp 600629

    Google Scholar 

  107. Komaki R, Cox JD (1994) The lung and thymus. In: Cox JD (ed) Moss’ radiation oncology: rationale, technique, results, 7th edn. Mosby, St. Louis, pp 320–351

    Google Scholar 

  108. Loeffler JS, Patchell RA, Saway AR (1997) Metastatic brain cancer. In: DeVita V Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 5th edn. Lippincott-Raven, Philadelphia, pp 2523–2536

    Google Scholar 

  109. Stoll BA (1983) Natural history, prognosis and staging of bone metastases. In: Stoll BA, Parboo S (eds) Bone metastases monitoring and treatment. Raven, New York, pp 1–20

    Google Scholar 

  110. Sculier JP, Feld R (1985) Superior vena cava obstruction syndrome: recommendations and management. Cancer Treat Rev 12: 210–218

    Google Scholar 

  111. Ychalom J (1997) Superior vena cava syndrome. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 5th edn. Lippincott-Raven, Philadelphia, pp 2469–2476

    Google Scholar 

  112. Langendijk JA, Ten Velde GPM, Aaronson NK et al (2000) Quality of life after palliative radiotherapy in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 47: 149–155

    Article  PubMed  CAS  Google Scholar 

  113. Simpson R, Francis ME, Perez-Tamayo R et al (1985) Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys 11: 751–758

    Article  PubMed  CAS  Google Scholar 

  114. Bleehen NM, Girling FJ, Mackin D, Stephens RJ (1992) A medical research council (MRC) randomized trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small cell lung cancer ( NSCLC) and poor performance status. Br J Cancer 65: 934–941

    Google Scholar 

  115. Langendijk JA, Aaronson JMA, de Jong GPM et al (2001) Prospective study on quality of life before and after radical radiotherapy in non-small cell lung cancer. J Clin Oncol 19: 2123–2133

    PubMed  CAS  Google Scholar 

  116. NCCN Practice Guidelines for Cancer-Related Fatigue (2000) Version 2000. Oncology 14: 151–161

    Google Scholar 

  117. Reddy SP, Marks JE (1990) Total atelectasis of the lung secondary to malignant airway obstruction. Am J Clin Oncol 13: 394–400

    Article  PubMed  CAS  Google Scholar 

  118. Kelly JF, Delclos ME, Morice RC et al High dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: the 10-year MD Anderson Cancer Center Experience. Int J Radiat Oncol Biol Phys 48: 697–702

    Google Scholar 

  119. Chetty KG, Moran EM, Sassoon CSH et al (1989) Effect of radiation therapy on bronchial obstruction due to bronchogenic carcinoma. Chest 96: 582–584

    Article  Google Scholar 

  120. Majid OA, Lee S, Khushalani S, Seydel HG (1986) The response of atelectasis from lung cancer to radiation therapy. Int J Radiat Oncol Biol Phys 12: 231–232

    Article  PubMed  CAS  Google Scholar 

  121. Chang L-FL, Horvath J, Peyton W, Lang S-S (1994) High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer. Int J Radiat Oncol Biol Phys 28: 589–596

    Article  PubMed  CAS  Google Scholar 

  122. Mehta M, Petereit D, Chosy L et al (1992) Sequential comparison of low dose rate and hyperfractionated high dose rate endobronchial radiation for malignant airway obstruction. Int J Radiat Oncol Biol Phys 23: 133–139

    Article  PubMed  CAS  Google Scholar 

  123. Raju PI, Roy T, McDonald RD et al (1993) Ir-192 low dose rate endobronchial brachytherapy in the treatment of malignant airway obstruction. Int J Radiat Oncol Biol Phys 27: 677–680

    Article  PubMed  CAS  Google Scholar 

  124. Spieser B, Spratling L (1990) Intermediate dose rate remote afterloading brachytherapy for intraluminal control of bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 18: 1443–1448

    Article  Google Scholar 

  125. McDonald AD, McDonald JC (1987) Epidemiology of malignant mesothelioma. In: Antman K, Aisner J (eds) Asbestos-related malignancy. Grune and Stratton, Orlando

    Google Scholar 

  126. Walker AM, Loughlin JE, Freidlander ER et al (1983) Projections of asbestos-related disease, 1980–2009. J Occup Med 25: 409–425

    PubMed  CAS  Google Scholar 

  127. Hogan MD, Hoel DG (1981) Estimated cancer risk associated with occupational asbestos exposure. Risk Anal 1: 67–73

    Article  Google Scholar 

  128. Wagner JC, Slegg CA, Marchand P (1960) Diffuse pleural mesotheliomas and asbestos exposure in Northwestern Cape Province. Br J Med 17: 260–271

    CAS  Google Scholar 

  129. Women inspectors of factories (1989) Annual Report for 1988. Her Majesty’s Stationery Office, London

    Google Scholar 

  130. Mossman BT, Gee JBL (1989) Asbestos-related diseases. N Engl J Med 320: 1721–1730

    Article  PubMed  CAS  Google Scholar 

  131. Wagner JC (1986) Mesothelioma and mineral fibers. Cancer 57: 1905–1911

    Article  PubMed  CAS  Google Scholar 

  132. Huncharek M (1992) Changing risk groups for malignant mesothelioma. Cancer 69: 2704–2711

    Article  PubMed  CAS  Google Scholar 

  133. Huncharek M (1994) Asbestos and cancer: epidemiological and public health controversies. Cancer Invest 12: 214–222

    Article  PubMed  CAS  Google Scholar 

  134. Connelly RR, Spirtas R, Myers MH et al (1987) Demographic patterns for mesothelioma in the United States. J Natl Cancer Inst 78: 1053–1060

    PubMed  CAS  Google Scholar 

  135. Antman KH, Pass HI (1997) Benign and malignant mesothelioma. In: DevVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer, principles and practice of oncology, 5th edn. Lippincott-Raven, Philadelphia, pp 1853–1878

    Google Scholar 

  136. Donna A, Betta PG (1981) Mesotheliomas: a new embryological approach to primary tumors of coelomic surfaces. Histopathology 5: 31–44

    Article  PubMed  CAS  Google Scholar 

  137. Gibbs AR, Harsch R, Wagner JC, Jasani B (1985) Comparison of tumor markers in malignant mesothelioma and pulmonary adenocarcinoma. Thorax 40: 91–95

    Article  PubMed  CAS  Google Scholar 

  138. Boutin C, Rey F, Gouvernet J et al (1993) Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 patients, part 2. Prognosis and staging. Cancer 73: 394–404

    Google Scholar 

  139. Antman KH, Shemin R, Ryan L et al (1988) Malignant mesothelioma: prognostic variables in a registry of 180 patients, The Dana Farber Cancer Institute and Brigham and Women’s Hospital experience over two decades, 1965–1985. J Clin Oncol 6: 147–153

    PubMed  CAS  Google Scholar 

  140. Rusch VW, Figlin R (2001) Pleural mesothelioma. In: Hjaskell CM (ed) Cancer Treatment, 5th ed. Saunders, Philadelphia, pp 639–645

    Google Scholar 

  141. Boutin C, Rey F, Gouvernet J et al (1993) Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 patients, part 1. Diagnosis. Cancer 72: 389–393

    Google Scholar 

  142. American Joint Committee on Cancer (1998) AJCC Cancer Staging Handbook. Pleural mesothelioma. Lippincott-Raven, Philadelphia, pp 129–131

    Google Scholar 

  143. Butchart EG, Ashcroft T, Barnsely WC, Holden MP (1981) The role of surgery in diffuse malignant mesothelioma of the pleura. Semin Oncol 8: 321–328

    PubMed  CAS  Google Scholar 

  144. DaVAlle MJ, Faber LP, Kittle CF (1986) Extrapleural pneumonectomy for diffuse malignant mesothelioma. Ann Thorac Surg 42: 612–618

    Article  PubMed  CAS  Google Scholar 

  145. Sugarbaker DJ, Strauss GM, Lynch TJ et al (1993) Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol 11: 1172–1178

    PubMed  CAS  Google Scholar 

  146. Allen KB, Faber LP, Warren WH (1994) Malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy. Chest Surg Clin North Am 4: 113–126

    CAS  Google Scholar 

  147. Burchart EG (1989) Surgery of mesothelioma of the pleura. In: Roth JH, Ruckdeschel JC, Weseinberger TH (eds) Thoracic oncology. Saunders, Philadelphia, pp 566–583

    Google Scholar 

  148. Wanebo HJ, Martini N, Melamed MR et al (1976) Pleural mesothelioma. Cancer 38: 2481–2488

    Article  PubMed  CAS  Google Scholar 

  149. Carmichael J, Degraff WG, Gamson J et al (1989) Radiation sensitivity of human lung cancer cell lines. Eur J Cancer Clin Oncol 25: 527–534

    Article  PubMed  CAS  Google Scholar 

  150. Rusch V, Saltz L, Venkatraman E et al (1994) A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol 12: 1156–1163

    PubMed  CAS  Google Scholar 

  151. Ruffle P, Fels R, Minkin S et al (1989) Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 7: 1157–1168

    Google Scholar 

  152. Gordon W, Antman KH, Breenberger J et al (1982) Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys 8: 19–25

    Article  PubMed  Google Scholar 

  153. De Graaf-Strukowska L, van der Zee J, van Putten W, Senan S (1999) Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura–a single institution experience with 189 patients. Int J Radiat Oncol Biol Phys 43: 511–516

    Article  PubMed  Google Scholar 

  154. Boutin C, Rey V, Vaillat J-R (1995) Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma: a randomized trial of local radiotherapy. Chest 108: 754–758

    Article  PubMed  CAS  Google Scholar 

  155. Maasilta P (1991) Deterioration in lung function following hemithorax irradiation for pleural mesothelioma. Int J Radiat Oncol Biol Phys 20: 433–438

    Article  PubMed  CAS  Google Scholar 

  156. Mattson K, Holsti LR, Tammilehto L et al (1992) Multimodality treatment programs for malignant pleural mesothelioma using high-dose hemithorax irradiation. Int J Radiat Oncol Biol Phys 24: 643–650

    Article  PubMed  CAS  Google Scholar 

  157. Hilaris BS, Dattatreyudu N, Kwong E et al (1984) Pleurectomy and intraoperative brachytherapy and postoperative radiation in the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 10: 325–331

    Article  PubMed  CAS  Google Scholar 

  158. Kutcher GJ, Kestler C, Greenblatt D et al (1987) Technique for external beam treatment for mesothelioma. Int J Radiat Oncol Biol Phys 13: 1747–1752

    Article  PubMed  CAS  Google Scholar 

  159. Herscher LL, Hahn SM, Kroog G et al (1998) Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small cell lung cancer. J Clin Oncol 16: 635–641

    PubMed  CAS  Google Scholar 

  160. Law MR, Gregor A, Hodson ME et al (1984) Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Thorax 39: 255–259

    Article  PubMed  CAS  Google Scholar 

  161. Brenner J, Sordillo PP, Magill GB, Golbey RB (1982) Malignant mesothelioma of the pleura. Review of 123 patients. Cancer 49: 2431–2435

    Article  PubMed  CAS  Google Scholar 

  162. Tion Ong S, Vogelzang N (1996) Chemotherapy in malignant pleural mesothelioma: a review. J Clin Oncol 14: 1007–1017

    Google Scholar 

  163. Krarup-Hansen A, Hansen HH (1991) Chemotherapy in malignant mesothelioma: a review. Cancer Chemother Pharmacol 28: 319–330

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, UCLA School of Medicine, University of California, Los Angeles, 200 UCLA Medical Plaza, Suite B265, 90095-6951, Los Angeles, CA, USA

    Robert G. Parker MD & Michael T. Selch MD

  2. Department of Radiation Oncology, M.D. Anderson Cancer Center, 77030, 1515 Holcombe Boulevard, Houston, TX, USA

    Nora A. Janjan MD

Authors
  1. Robert G. Parker MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nora A. Janjan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael T. Selch MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Parker, R.G., Janjan, N.A., Selch, M.T. (2003). Lung Cancer and Pleural Mesothelioma. In: Radiation Oncology for Cure and Palliation. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-05225-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-05225-9_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-07466-0

  • Online ISBN: 978-3-662-05225-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation